When is Premier Biomedical’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
Is Premier Biomedical overvalued?
Not enough analysts have published a price target to calculate whether the price is overvalued.
Does Premier Biomedical pay dividends?
Premier Biomedical does not currently pay dividends.
What is Premier Biomedical’s EPS estimate?
Premier Biomedical’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Premier Biomedical have?
Premier Biomedical has 1,689,881,000 shares outstanding.
Which hedge fund is a major shareholder of Premier Biomedical?
Currently, no hedge funds are holding shares in BIEI
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Premier Biomedical
Premier Graphene Inc. focuses on graphene and other carbon nanomaterials, including hemp-based graphene, graphene oxide, reduced graphene oxide, and carbon nanotubes. Its materials are intended for commercial and military applications, including defense and energy.